Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has announced an on-market buy-back of its shares, with 4,000 ordinary shares purchased on the previous day, adding to a total of 19,505 shares bought back to date. This latest financial maneuver, part of an ongoing effort to reacquire shares, was detailed in their April 29, 2024 update to the market.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
